21.03.2018 08:54:03
|
Notice Convening the Annual General Meeting
March 21, 2018
Announcement no. 6
Notice Convening the Annual General Meeting
The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S:
April 13, 2018, at 3.00 pm (CET),
At the Company’s address
Tuborg Havnevej 15, st., DK-2900 Hellerup
(Parking in Waterfront Shopping)
Agenda:
- Report of the Company’s activities during the past year
- Presentation of the annual report for approval and allocation of profit or covering of loss
- Resolution to grant discharge of liability to the Board of Directors and Executive Management
- Approval of remuneration for the Board of Directors
- Election of members to the Board of Directors
- Proposals from the Board of Directors
A) Proposal to amend article 18 in the Articles of Association to renew the authorisation to issue warrants - Election of auditor
- Any other business
BioPorto A/S
The Board of Directors
Further information:
Gry Husby Larsen
Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bioporto A-Smehr Nachrichten
16.12.24 |
BioPorto commences process to appoint new Chair of the Board of Directors (GlobeNewswire) | |
13.11.24 |
Ausblick: Bioporto A-S stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
30.10.24 |
Erste Schätzungen: Bioporto A-S stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
29.10.24 |
First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital (GlobeNewswire) | |
28.10.24 |
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests (GlobeNewswire) |
Analysen zu Bioporto A-Smehr Analysen
Aktien in diesem Artikel
Bioporto A-S | 1,56 | -0,77% |